Searched for
LIVER DISEASE DRUG
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Death rate in ICE immigrant detention centers more than doubles under Trump, Reuters analysis findsFifty individuals have died in U.S. immigration detention since January 2025, a rate that has more than doubled since 2009. Concerns are ri...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- Quote of the day by George Michael: 'I seem to think that anything worth having in life has to be...' Life lessons on goals, success, hard work and hardships by British singer and songwriterQuote of the day by George Michael highlights the connection between success, hard work, goals, and hardships. The quote explains that many...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...
- Quote of the day by George Michael: 'Change is a stranger you have yet to know.' Life lessons on human nature, success and hardships by British singer and songwriterQuote of the day by George Michael explores the meaning of change through the words “Change is a stranger you have yet to know.” The articl...
- Who is Ashok Bahar? The 71-year-old who appeared for NEET to fulfil a promise to his mother, only for 2026 paper leak to change everythingNEET UG 2026 paper leak: Ashok Bahar, a 71-year-old from Uttar Pradesh, pursued his lifelong dream of becoming a doctor by appearing for th...
- Age no limit: 71-year-old, who attempts NEET after retirement makes Internet emotional - 'Your mum is cheering...'A 71-year-old man from Lucknow, Ashok Bahar, is pursuing his lifelong dream of becoming a doctor by appearing for the NEET examination. Ins...
- Deadly fatty liver could be reversed with this surprising two-drug heart combo, as per doctorsDoctors have found hope for fatty liver disease using two common heart drugs. The new study from the University of Barcelona shows this com...
- Roche to acquire liver drug developer 89bio for up to $3.5 billionRoche is set to acquire 89bio for up to $3.5 billion, gaining access to the promising liver disease drug pegozafermin. This move complement...
- GSK to buy liver disease drug from Boston Pharmaceuticals for up to $2 billionGSK is set to acquire efimosfermin, a promising liver disease drug, from Boston Pharmaceuticals for a potential $2 billion. The deal includ...
Load More
